ArticleCell death & disease2022

SGLT2 inhibitor activates the STING/IRF3/IFN-β pathway and induces immune infiltration in osteosarcoma.

Wei Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.